These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18604384)

  • 1. [Continuous subcutaneous insulin infusion in type 1 diabetic during pregnancy: case report and literature review].
    Reis JS; Lamounier RN; Menezes PA; Calsolari MR; Purisch S
    Arq Bras Endocrinol Metabol; 2008 Jun; 52(4):697-700. PubMed ID: 18604384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
    Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R
    Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy.
    Neff KJ; Forde R; Gavin C; Byrne MM; Firth RG; Daly S; McAuliffe FM; Foley M; Coffey M; Coulter-Smith S; Kinsley BT
    Ir J Med Sci; 2014 Sep; 183(3):397-403. PubMed ID: 24142539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
    González-Romero S; González-Molero I; Fernández-Abellán M; Domínguez-López ME; Ruiz-de-Adana S; Olveira G; Soriguer F
    Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
    Giménez M; Conget I; Nicolau J; Pericot A; Levy I
    Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials.
    Mukhopadhyay A; Farrell T; Fraser RB; Ola B
    Am J Obstet Gynecol; 2007 Nov; 197(5):447-56. PubMed ID: 17678864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion for managing diabetes: women's health implications.
    Hood DG
    Nurs Womens Health; 2012; 16(4):308-18. PubMed ID: 22900807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
    Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
    Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections.
    Cypryk K; Kosiński M; Kamińska P; Kozdraj T; Lewiński A
    Pol Arch Med Wewn; 2008 Jun; 118(6):339-44. PubMed ID: 18619188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
    Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women.
    Mello G; Biagioni S; Ottanelli S; Nardini C; Tredici Z; Serena C; Marchi L; Mecacci F
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):276-80. PubMed ID: 24724804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
    Farrar D; Tuffnell DJ; West J
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005542. PubMed ID: 17636806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion.
    Rieger C; Kurz K; Mueller-Hoffmann W; Gehr B; Liebl A
    J Diabetes Sci Technol; 2019 Nov; 13(6):1158-1160. PubMed ID: 31195815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications for the use of continuous subcutaneous insulin infusion in pediatric patients with type 1 diabetes mellitus].
    Espejel-Huerta D; Antillón-Ferreira CA; Iglesias-Leboreiro J; Bernárdez-Zapata I; Martínez-Ramos Méndez A; Rendón-Macías ME
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):64-9. PubMed ID: 26820201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of continuous intravenous insulin infusion in type 1 diabetic pregnancy complicated by nephrotic syndrome.
    Dudding S; Whitelaw D
    Diabetes Res Clin Pract; 2011 Jul; 93(1):e53-6. PubMed ID: 21543130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous subcutaneous insulin infusion (CSII) pumps.
    Valla V
    Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring and insulin pump therapy for diabetes in pregnancy.
    Combs CA
    J Matern Fetal Neonatal Med; 2012 Oct; 25(10):2025-7. PubMed ID: 22384837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.